PortfoliosLab logo
BHC vs. NEM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BHC and NEM is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

BHC vs. NEM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bausch Health Companies Inc. (BHC) and Newmont Goldcorp Corporation (NEM). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BHC:

-0.54

NEM:

0.61

Sortino Ratio

BHC:

-0.52

NEM:

1.08

Omega Ratio

BHC:

0.93

NEM:

1.15

Calmar Ratio

BHC:

-0.33

NEM:

0.48

Martin Ratio

BHC:

-1.32

NEM:

1.39

Ulcer Index

BHC:

24.17%

NEM:

17.99%

Daily Std Dev

BHC:

56.94%

NEM:

36.93%

Max Drawdown

BHC:

-98.35%

NEM:

-77.55%

Current Drawdown

BHC:

-98.18%

NEM:

-34.08%

Fundamentals

Market Cap

BHC:

$1.70B

NEM:

$56.52B

EPS

BHC:

-$0.12

NEM:

$4.39

PEG Ratio

BHC:

0.63

NEM:

0.79

PS Ratio

BHC:

0.17

NEM:

2.87

PB Ratio

BHC:

18.78

NEM:

1.92

Total Revenue (TTM)

BHC:

$9.60B

NEM:

$19.65B

Gross Profit (TTM)

BHC:

$6.21B

NEM:

$7.72B

EBITDA (TTM)

BHC:

$2.49B

NEM:

$9.78B

Returns By Period

In the year-to-date period, BHC achieves a -40.69% return, which is significantly lower than NEM's 37.24% return. Over the past 10 years, BHC has underperformed NEM with an annualized return of -32.04%, while NEM has yielded a comparatively higher 8.81% annualized return.


BHC

YTD

-40.69%

1M

10.65%

6M

-48.88%

1Y

-30.52%

5Y*

-21.90%

10Y*

-32.04%

NEM

YTD

37.24%

1M

-7.62%

6M

21.39%

1Y

22.25%

5Y*

-1.35%

10Y*

8.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BHC vs. NEM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BHC
The Risk-Adjusted Performance Rank of BHC is 2020
Overall Rank
The Sharpe Ratio Rank of BHC is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of BHC is 2121
Sortino Ratio Rank
The Omega Ratio Rank of BHC is 2020
Omega Ratio Rank
The Calmar Ratio Rank of BHC is 2727
Calmar Ratio Rank
The Martin Ratio Rank of BHC is 1111
Martin Ratio Rank

NEM
The Risk-Adjusted Performance Rank of NEM is 7070
Overall Rank
The Sharpe Ratio Rank of NEM is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of NEM is 6969
Sortino Ratio Rank
The Omega Ratio Rank of NEM is 7070
Omega Ratio Rank
The Calmar Ratio Rank of NEM is 7171
Calmar Ratio Rank
The Martin Ratio Rank of NEM is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BHC vs. NEM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and Newmont Goldcorp Corporation (NEM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BHC Sharpe Ratio is -0.54, which is lower than the NEM Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of BHC and NEM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

BHC vs. NEM - Dividend Comparison

BHC has not paid dividends to shareholders, while NEM's dividend yield for the trailing twelve months is around 1.97%.


TTM20242023202220212020201920182017201620152014
BHC
Bausch Health Companies Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NEM
Newmont Goldcorp Corporation
1.97%2.69%3.87%4.66%3.55%1.74%3.31%1.62%0.67%0.37%0.56%1.19%

Drawdowns

BHC vs. NEM - Drawdown Comparison

The maximum BHC drawdown since its inception was -98.35%, which is greater than NEM's maximum drawdown of -77.55%. Use the drawdown chart below to compare losses from any high point for BHC and NEM. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BHC vs. NEM - Volatility Comparison

Bausch Health Companies Inc. (BHC) has a higher volatility of 23.08% compared to Newmont Goldcorp Corporation (NEM) at 13.82%. This indicates that BHC's price experiences larger fluctuations and is considered to be riskier than NEM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BHC vs. NEM - Financials Comparison

This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Newmont Goldcorp Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B3.00B4.00B5.00B6.00B20212022202320242025
2.23B
5.01B
(BHC) Total Revenue
(NEM) Total Revenue
Values in USD except per share items

BHC vs. NEM - Profitability Comparison

The chart below illustrates the profitability comparison between Bausch Health Companies Inc. and Newmont Goldcorp Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-40.0%-20.0%0.0%20.0%40.0%60.0%80.0%20212022202320242025
68.5%
46.1%
(BHC) Gross Margin
(NEM) Gross Margin
BHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bausch Health Companies Inc. reported a gross profit of 1.53B and revenue of 2.23B. Therefore, the gross margin over that period was 68.5%.

NEM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Newmont Goldcorp Corporation reported a gross profit of 2.31B and revenue of 5.01B. Therefore, the gross margin over that period was 46.1%.

BHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bausch Health Companies Inc. reported an operating income of 276.00M and revenue of 2.23B, resulting in an operating margin of 12.4%.

NEM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Newmont Goldcorp Corporation reported an operating income of 2.02B and revenue of 5.01B, resulting in an operating margin of 40.2%.

BHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bausch Health Companies Inc. reported a net income of -58.00M and revenue of 2.23B, resulting in a net margin of -2.6%.

NEM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Newmont Goldcorp Corporation reported a net income of 1.89B and revenue of 5.01B, resulting in a net margin of 37.7%.